no hepatic metastases; AND • Must not be used in combination with chemotherapy; AND • Patient’s l ife expectancy is estimated to be greater than 6 months; AND • Patient is asymptomatic or minimally symptomatic; AND • Patient has not previously received therapy with sipuleucel-T ...